Yan Leyfman: Honored to participate in the Legorreta Cancer Center’s Symposium on Tumor Plasticity in Diagnosis and Treatment.

Yan Leyfman, Internal Medicine & Clinical Researcher at Icahn School of Medicine at Mount Sinai, made the following post on LinkedIn:

“Honored to participate in the Legorreta Cancer Center’s Symposium on Tumor Plasticity in Diagnosis and Treatment, where I had the privilege of presenting our latest research on the Cancer COVID-19 Nexus. My heartfelt thanks go to the exceptional organizers, Drs. Sendurai Mani and Wafik S. El-Deiry, MD, PhD, FACP, for curating such an outstanding event featuring the foremost global leaders in the field.

The opportunity to learn from the diverse array of speakers was truly enriching. It was an extraordinary privilege to meet luminaries such as 2019 Nobel Laureate Dr. William Kaelin (Dana-Farber Cancer Institute), the distinguished Global Precision Medicine Leader Dr. Vivek Subbiah, MD (Sarah Cannon Research Institute), and the esteemed Immunotherapy Expert Dr. Gordon Freeman (Dana-Farber Cancer Institute).

These interactions have further fueled my passion for advancing cancer research and treatment. I am deeply grateful for the insights shared and the connections made during this remarkable symposium.”

Source: Yan Leyfman/Twitter